CLIA Laboratory Citation Details
49D2135624
Survey Type: Standard
Survey Event ID: 39JQ11
Deficiency Tags: D0000 D2093 D2123 D3031 D5400 D5429 D5437 D5791 D5793 D6000 D6017 D6022 D6029 D6053 D6054 D2093 D2123 D3031 D5400 D5429 D5437 D5791 D5793 D6000 D6017 D6022 D6029 D6053 D6054
Summary Statement of Deficiencies D0000 An announced CLIA validation survey was conducted at Valley Health Urgent Care - Rutherford Crossing on October 3, 2024 by the Virginia Department of Health's Office of Licensure and Certification. The laboratory was surveyed under 42 CFR part 493 CLIA Regulations. Specific deficiencies cited are as follows and include the Conditions under 42 CFR part 493 CLIA Regulation: D5400 - 42 CFR. 493.1250 Analytic Systems D6000 - 42 CFR. 493.1403 Laboratory Director. D2093 ROUTINE CHEMISTRY CFR(s): 493.841(d) Failure to return proficiency testing results to the proficiency testing program within the time frame specified by the program is unsatisfactory performance and results in a score of 0 for the testing event. This STANDARD is not met as evidenced by: Based on a review of the laboratory's proficiency testing (PT) documentation, and an interview, the laboratory failed to ensure Chemistry Module PT test results for Sodium (Na), Potassium (K), Chloride (Cl), Glucose (Gluc), Urea Nitrogen (BUN), and Creatinine (Creat) were returned to American Association of Bioanalysts/Medical Laboratory Evaluation (AAB/MLE) within the program's deadline for one (1) of three (3) events in calendar year 2023. The findings include: 1. Review of the laboratory's 2023 AAB/MLE Chemistry PT documentation (Events 1-3) revealed that the laboratory failed to submit PT results and received failure to participate scores for the following modules/analytes: 2023 Chemistry-Event 2: five of five samples received zero percent (0%) scores for Na, K, Cl, Gluc, BUN, and Creat for samples CHM 06- 10. 2. In an interview with the Laboratory Director (LD) on October 3, 2024 at 10:00 AM, the LD stated "The testing was performed but we did not submit the results in time." D2123 HEMATOLOGY Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 9 -- CFR(s): 493.851(c) Failure to participate in a testing event is unsatisfactory performance and results in a score of 0 for the testing event. Consideration may be given to those laboratories failing to participate in a testing event only if-- (1) Patient testing was suspended during the time frame allotted for testing and reporting proficiency testing results; (2) The laboratory notifies the inspecting agency and the proficiency testing program within the time frame for submitting proficiency testing results of the suspension of patient testing and the circumstances associated with failure to perform tests on proficiency testing samples; and (3) The laboratory participated in the previous two proficiency testing events. This STANDARD is not met as evidenced by: Based on a review of the laboratory's proficiency testing (PT) documentation, and an interview, the laboratory failed to ensure Non-Chemistry Module PT test results for Erythrocyte Count (RBC), Hematocrit (HCT), Hemoglobin (HBG), Leukocyte Count (WBC), Platelets (PLT) and WBC Differential (Diff) were returned to American Association of Bioanalysts/Medical Laboratory Evaluation (AAB/MLE) within the program's deadline for one (1) of three (3) events in calendar year 2023. The findings include: 1. Review of the laboratory's 2023 AAB/MLE Non-Chemistry PT documentation (Events 1-3) revealed that the laboratory failed to submit results and received failure to participate scores for the following modules/analytes: 2023 Non- Chemistry-Event 2: five of five samples received zero percent (0%) scores for RBC, HCT, HGB, WBC, Diff for samples NCH 06-10. 2. In an interview with the Laboratory Director (LD) on October 3, 2024 at 10:00 AM, the LD stated "The testing was performed but we did not submit the results in time." D3031 RETENTION REQUIREMENTS CFR(s): 493.1105(a)(3) Analytic systems records. Retain quality control and patient test records (including instrument printouts, if applicable) and records documenting all analytic systems activities specified in 493.1252 through 493.1289 for at least 2 years. This STANDARD is not met as evidenced by: Based on a review of the laboratory's policy and procedures, temperature log sheets, lack of documentation and interview, the laboratory failed to follow their established policy and retain documentation of the monitoring and recording of daily refrigerator, freezer, room temperature and humidity from January 1, 2023 until December 31, 2023 (12 Months). The findings include: 1. Review of the laboratory's "Rutherford Urgent Care Daily Maintenance Log" revealed a statement in the header, "All staff are responsible for completing every task on the log, initial in the box that it has been performed." Further review of the "AM Maintenance" section listed a task "Record Temp/Humidity". Review of the maintenance logs sheets revealed staff initials in the boxes indicating staff completion of the tasks from July 2002 until July 2024. 2. Review of the available laboratory temperature log sheets from July 2022 until July 2024 revealed a lack of temperature log sheets from January 1, 2023 until December 31, 2023 (12 Months). The surveyor requested to review the temperature logs from January 1, 2023 until December 31, 2023. The laboratory provided no documentation to review. 3. Review of the laboratory's policy and procedures revealed a policy, "Lab Monitors", revealed a statement "All forms are kept for 2 years per COLA -- 2 of 9 -- requirements." 4. In an exit interview with the Laboratory Director (LD) on October 3, 2024 at 12:15 PM, the findings were confirmed. D5400 ANALYTIC SYSTEMS CFR(s): 493.1250 Each laboratory that performs nonwaived testing must meet the applicable analytic systems requirements in 493.1251 through 493.1283, unless HHS approves a procedure, specified in Appendix C of the State Operations Manual (CMS Pub.7), that provides equivalent quality testing. The laboratory must monitor and evaluate the overall quality of the analytic systems and correct identified problems as specified in 493.1289 for each specialty and subspecialty of testing performed. This CONDITION is not met as evidenced by: Based on a review of the laboratory's policies and procedures, manufacturer's instrument instruction manuals, maintenance records, Quality Control records (QC), calibration records, Quality Assessment (QA) records, lack of documentation, and interviews, the laboratory failed to: 1. document performance of the required monthly maintenance for the Medonic M Series Hematology analyzer (see D5429A). 2. document performance of the required six-month cleaning procedures for the Medonic M Series Hematology analyzer (see D5429B). 3. document calibration procedures every six (6) months for Complete Blood Count (CBC) testing on the Medonic M Series Hematology analyzer (see D5437). 4. perform Levy-Jennings (LJ) chart evaluations for QC shifts and trends for Hematology CBC testing(see D5791A). 5. follow their established QA plan to identify and address analytic issues with the specialty of Hematology (see D5791B). 6. follow their established QA plan to identify and correct issues with Hematology QC and calibration (see D5793). D5429 MAINTENANCE AND FUNCTION CHECKS CFR(s): 493.1254(a)(1) For unmodified manufacturer's equipment, instruments, or test systems, the laboratory must perform and document maintenance as defined by the manufacturer and with at least the frequency specified by the manufacturer. This STANDARD is not met as evidenced by: A. Based on a review of the laboratory's policies and procedures, Medonic M Series Hematology analyzer's maintenance instructions and records, lack of documentation, and an interview, the laboratory failed to document performance of required monthly instrument preventative maintenance for six (6) of twenty-four (24) months reviewed from July 2022 until July 2024. The findings include: 1. Review of the laboratory's "Medonic M Series Maintenance" instructions (pages 1-2) revealed instructions for performing "Monthly Cleaning Procedure", utilizing the Boule Cleaning Kit's hypochlorite and enzymatic cleaners. 2. Review of the laboratory's "Medonic M- Series Hematology Analyzer" log sheets from July 2022 until July 2024 revealed a lack of documentation of the required "Monthly Maintenance" during the following months: August 2022, July 2023, August 2023, September 2023, February 2024 and July 2024. The surveyor requested to review documentation of the monthly cleaning maintenance for the six months listed above. The laboratory provided no documentation to review. 3. In an exit interview with the Laboratory Director (LD) on October 3, 2024 at 12:15 PM, the findings were confirmed. B. Based on a review of -- 3 of 9 -- the laboratory's policies and procedures, Medonic M Series Hematology analyzer's maintenance instructions and records, lack of documentation, and an interview, the laboratory failed to document performance of two (2) of four (4) required six-month cleaning procedures as required in calendar year 2023 until July 2024. The findings include: 1. Review of the "Medonic M Series Maintenance" instructions (page 2) revealed instructions for performing the six month cleaning procedures utilizing the Boule Cleaning Kit's enzymatic, hypochlorite and detergent cleaners. 2. Review of the laboratory's "Medonic M-Series Hematology Analyzer" log sheets from July 2022 to July 2024 revealed documentation of the required "Six Month maintenance" utilizing the Boule Cleaning Kit during the following months: December 2022, July 2023, and January 2024. The surveyor requested to review documentation of the six-month cleaning maintenance for June 2023 and July 2024. The laboratory provided no documentation to review. 3. In an exit interview with the Laboratory Director (LD) on October 3, 2024 at 12:15 PM, the findings were confirmed. D5437 CALIBRATION AND CALIBRATION VERIFICATION CFR(s): 493.1255(a) Unless otherwise specified in this subpart, for each applicable test system the laboratory must perform and document calibration procedures-- (1) Following the manufacturer's test system instructions, using calibration materials provided or specified, and with at least the frequency recommended by the manufacturer; (2) Using the criteria verified or established by the laboratory as specified in 493.1253(b) (3)-- (2)(i) Using calibration materials appropriate for the test system and, if possible, traceable to a reference method or reference material of known value; and (2)(ii) Including the number, type, and concentration of calibration materials, as well as acceptable limits for and the frequency of calibration; and (3) Whenever calibration verification fails to meet the laboratory's acceptable limits for calibration verification. This STANDARD is not met as evidenced by: Based on a review of the laboratory's policies and procedures, Hematology calibration records, lack of documentation, and an interview, the laboratory failed to document calibration procedures every six (6) months for Complete Blood Count (CBC) testing according to the manufacturer's instructions for two (2) of four (4) calibrations during the twenty-four months reviewed from July 2022 until July 2024. The findings include: 1. Review of the laboratory's procedures revealed a procedure "Medonic M Series hematology analyzer" procedure (page 7), "CALIBRATION-Calibration must be performed upon setup of the instrument and then at a minimum of every 6 months." 2. Review of the laboratory's Medonic instrument's CBC calibration records from July 2022 until July 2024, revealed calibration documentation on 12/20/2022, and 7/7/2023. The surveyor noted that a 6 month calibration would have been due in June 2023, and January 2024. The surveyor requested to review the calibration documents for the months listed above. The laboratory provided no additional records to review. 3. An exit interview with the Laboratory Director (LD) on October 3, 2024 at 12:15 PM confirmed the findings. D5791 ANALYTIC SYSTEMS QUALITY ASSESSMENT CFR(s): 493.1289(a)(c) (a) The laboratory must establish and follow written policies and procedures for an ongoing mechanism to monitor, assess, and when indicated, correct problems identified in the analytic systems specified in 493.1251 through 493.1283. (c) The -- 4 of 9 -- laboratory must document all analytic systems assessment activities. This STANDARD is not met as evidenced by: A. Based on a review of the laboratory's daily maintenance log, Hematology Quality Control (QC) records, lack of documentation, and interview, the laboratory failed to follow their established policy and document Levy-Jennings (LJ) chart evaluations for Hematology QC shifts and trends for twenty-four (24) of 24 months reviewed from July 2022 until July 2024. The findings include: 1. Review of the laboratory's "Daily Maintenance Log" included a statement in the header, "All staff are responsible for completing every task on the log. Initial in the box that it has been performed." Further review of the "Weekly Maintenance" listed a section "Medonic Weekly LJ review". Review of the July 2022 to July 2024 logs revealed no initials in the "Medonic Weekly IJ review" boxes from July 2022 until July 2024. 2. The surveyor requested to review documentation of the weekly LJ review. The laboratory provided no documentation for review. 3. In an exit interview with the Laboratory Director on October 3, 2024 at 12:15 PM, the findings were confirmed. B. Based on the review of the laboratory's policies and procedures, instrument maintenance records, calibration verification records, quality control (QC) records, lack of documentation and interviews, the laboratory failed to follow their established Quality Assessment (QA) plan to identify and address analytic issues within the specialties of Hematology (See D 5429, 5437 and 5793) from July 2022 until July 2024 (24 months). The findings include: 1. Review of the laboratory's Quality Assessment (QA) policies and procedures, instrument maintenance, calibration verification and quality control revealed the analytic issues listed below. The laboratory failed to follow their established policy to document : -the monthly and semi-annual maintenance on the Medonic M-Series Hematology analyzer (see D5429). -the every 6 month calibration during the twenty-four (24) months reviewed (see D5437). -the review of "
Get full access to the detailed deficiency summary for this facility